Literature DB >> 10803769

Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis.

S Feriozzi1, A O Muda, V Gomes, M Montanaro, T Faraggiana, E Ancarani.   

Abstract

We report a case of reversible acute renal failure after cefotaxime treatment in a patient affected by non-Hodgkin lymphoma. Renal biopsy showed necrotizing vasculitis associated with eosinophil-rich interstitial inflammatory infiltrates and patchy infiltrates of CD20+ lymphoid cells. High serum p-ANCA titers were also detected. Drug withdrawal was closely related with recovery of renal function and disappearance of ANCA. Acute renal failure therefore represented a consequence of ANCA-mediated renal vasculitis and acute interstitial nephritis related to cefotaxime treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803769     DOI: 10.1081/jdi-100100869

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

1.  Rare adverse effect of a common drug: nitrofurantoin-induced ANCA-associated vasculitis.

Authors:  Abhishek Agarwal; Abhinav Agrawal; Karim Nathan; Satyajeet Roy
Journal:  BMJ Case Rep       Date:  2015-05-02

2.  Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.

Authors:  Hideki Ueda; Eiji Ishimura; Takayuki Yunoki; Takao Tsuchida; Naoki Matsumoto; Syuichi Jono; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 3.  Drug-induced glomerular disease: immune-mediated injury.

Authors:  Jonathan J Hogan; Glen S Markowitz; Jai Radhakrishnan
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-19       Impact factor: 8.237

Review 4.  Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Cheng-Hua Weng; Zhi-Chun Liu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

Review 5.  Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report.

Authors:  Keita Morimoto; Go Kanzaki; Takahito Niikura; Kentaro Koike; Nanae Matsuo; Yukio Maruyama; Nobuo Tsuboi; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2021-08-30       Impact factor: 2.388

6.  Hypersensitivity vasculitis induced by cefoperazone/sulbactam.

Authors:  Ismail Islek; Sancar Baris; Ali O Katranci; Ender Ariturk; Nuran Gurses
Journal:  Ann Clin Microbiol Antimicrob       Date:  2003-01-03       Impact factor: 3.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.